EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy

Tingting Wang, Jinnan Wang, Wei Zhao, Yueyin Pan

Clinical Breast Cancer · 2024

DOI: 10.1016/j.clbc.2024.02.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2024. Verfasst von Tingting Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui Province, China, 230032. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen, Receptors, Progesterone, Neoadjuvant Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, EstrogenReceptors, ProgesteroneNeoadjuvant TherapyErb-b2 Receptor Tyrosine KinasesHumansFemaleMiddle AgedAdultAntineoplastic Combined Chemotherapy ProtocolsAgedPrognosisChemotherapy, AdjuvantBiomarkers, TumorRetrospective Studies

Stichwörter der Autor:innen

Breast tumorEndocrine therapyMolecular subtypePathologic complete responsePrognosis

Substanzen

Receptors, EstrogenReceptors, ProgesteroneErb-b2 Receptor Tyrosine KinasesBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui Province, China, 230032.
  • Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China.
  • Department of Medical Oncology, Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui Province, China, 230032. Electronic address: panyueyin@ustc.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, T., Wang, J., Zhao, W., & Pan, Y. (2024). Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.02.016

Vancouver

Wang T, Wang J, Zhao W, Pan Y. Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy. Clinical Breast Cancer. 2024. doi:10.1016/j.clbc.2024.02.016

BibTeX
@article{Wang2024,
  author = {Wang, Tingting and Wang, Jinnan and Zhao, Wei and Pan, Yueyin},
  title = {Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy},
  journal = {Clinical Breast Cancer},
  year = {2024},
  doi = {10.1016/j.clbc.2024.02.016}
}
Kostenlos starten →